Home Sign In About Curriculum Activity Information Target Audience Learning Objectives Technical Requirements
The Curriculum in Iron Metabolism & Related Disorders is supported by an educational grant from
Novartis Oncology

Created in consultation with
Projects In Knowledge®, developers of certificate programs in medicine.

Projects In Knowledge is a registered trademark of Projects In Knowledge, Inc.

Course materials have been developed for use outside of the United States.
banner

Slides  |   Abstract  |   Learning Objectives  |   Disclosure Information  |   Posttest  |   Technical Requirements

Diagnosis of Iron Overload


Transfusion-dependent patients are at risk of iron overload and, therefore, require careful monitoring to avoid the morbidity and mortality associated with excess iron. In this webcast, Dr. Domenica Cappellini discusses the advantages and disadvantages of various methods of assessing iron overload and how best to utilize test results in managing patients.
Faculty
Maria D. Cappellini, MD
Maria D. Cappellini, MD
Professor of Internal Medicine
University of Milan
Maggiore Hospital
Milan, Italy

Target Audience

This activity is designed for haematologists, medical oncologists, haematology-oncology specialists, and other healthcare professionals involved in the screening, evaluation, treatment, and management of adults and children with iron overload, resulting from the spectrum of chronic iron overload diseases.

Learning Objectives


After participating in this activity, participants should be better able to:
  • Compare the pros and cons of the established methods (LIC and serum ferritin), as well as investigational methods, for measuring iron levels.
  • Through a better understanding of the pros and cons of each methodology for measuring iron levels, select appropriate methods for measuring iron levels (including LIC) in assessing patients at risk for iron overload in the practice setting.
Disclosure Information

Maria D. Cappellini, MD, is a consultant for and on the speakers bureau of Novartis Pharmaceuticals Corporation. Prof. Cappellini has disclosed that she will not reference any unlabeled/unapproved uses of drugs or devices.

top

View Webcast

- requires Flash & high-speed Internet
(Tech. Requirements)


Download Slides

Ask the Experts   New!


 
ESH-Centre Hayem, Hôspital Saint-Louis, 1 avenue Claude Vellefaux, 75475 Paris Cedex 10, France - Contacts
All Rights Reserved - Copyright ESH 2010